IsoPlexis Corp (ISO) Stock

DelistedNasdaq: ISOIsoPlexis Corporation, a life sciences company, provides solutions for the development of curative medicines and personalized therapeutics in the United States, Canada, the United Kingdom, Belgium, France, the Czech Republic, Spain, Germany, Sweden, Italy, Israel, Switzerland, China and Taiwan, Singapore, Japan, Australia, and Korea.

0.76
Final close · Mar 20, 2023

ISO is no longer traded. IsoPlexis was delisted from the Nasdaq in March 2023.

Prices on this page are historical; the last trade was March 20, 2023 at $0.76.

IsoPlexis stock price history

Split-adjusted closes, 2021–2023

ISO final trading statistics

Final close
$0.76
Final trading day
Mar 20, 2023
Market cap at delisting
$30.28M
Shares outstanding
39.76M
Final 52-week range
$0.60 – $5.10
Avg. volume (final 3 mo.)
987,032
All-time high (split-adj.)
$15.70 · Nov 2021
All-time low (split-adj.)
$0.66 · Dec 2022
Return since IPO
-93.4%
Beta
—
Book value / share
$1.04
Price / book
0.73
Final 52 wk
0.605.10

IsoPlexis earnings per share

Earnings per share

IsoPlexis revenue & net income

RevenueNet income

IsoPlexis annual financials

IsoPlexis Corp revenue, net income and EPS by fiscal year
Fiscal yearRevenueNet incomeEPS
FY2022$16.76M-$115.5M-$2.70
FY2021$17.3K$76.2M-$100.59
FY2020$10.39M-$23.3M-$92.88
FY2019$7.50M-$13.6M-$28.11

Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.

About IsoPlexis Corp

IsoPlexis Corporation, a life sciences company, provides solutions for the development of curative medicines and personalized therapeutics in the United States, Canada, the United Kingdom, Belgium, France, the Czech Republic, Spain, Germany, Sweden, Italy, Israel, Switzerland, China and Taiwan, Singapore, Japan, Australia, and Korea. The company offers single cell proteomics platform, including instruments, chip consumables, and software that provides an end-to-end solution to view of protein function at an individual cellular level. It provides IsoLight and IsoSpark instruments; IsoCode chips that offer multiplexed chip solutions for single cell functional proteomics; CodePlex chips that provide multiplexed solutions for ultra-low volume bulk samples; and IsoSpeak software that offers dimensional data and automates analysis with an intuitive push button user interface to deliver same day single cell and bulk proteome visualizations, as well as research support and services, and post-warranty services. The company was incorporated in 2013 and is based in Branford, Connecticut. As of March 21, 2023, IsoPlexis Corporation operates as a subsidiary of Berkeley Lights, Inc.

IsoPlexis stock FAQ

What happened to IsoPlexis stock?

IsoPlexis stock was delisted from the Nasdaq. Its final close was $0.76 on March 20, 2023.

Is ISO stock still trading?

No. ISO was delisted from the Nasdaq in March 2023 and no longer trades on a U.S. exchange.

What was the last price of ISO stock?

ISO closed at $0.76 on its final trading day, March 20, 2023, for a market value of about $30.28M.

What were IsoPlexis's revenue and earnings in its last full fiscal year?

IsoPlexis reported revenue of $16.76M and net income of -$115.5M in fiscal 2022, its last full year as a public company.

When did IsoPlexis go public?

IsoPlexis Corp stock began trading on October 8, 2021.

Medical Devices stocks to research

All Healthcare stocks →